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PROBLEM

OBJECTIVE

RESULTS

CONCLUSIONS

In the Aurora Sinai Internal Medicine Clinic, breast
cancer screening has been below expectations for
years which reflects to under achieved Quality
measures.

The USPSTF guideline for BCS is a Quality
Improvement (QI) measure that is tracked for
Primary Care Physicians (PCPs) in Advocate
Aurora Health. The primary care providers (PCPs)
in our clinic had a combined BCS of 67 % for
Group 1 and 73% for Group 2 for the eligible
patient assigned to them at September 2019
(system goal was ≥ 84%). We hypothesized that
regular BCS has been limited by factors including
inadequate emphasis, education, and reminders
for BCS. Our goal was to fill these gaps and
improve patient outcomes by increasing our BCS
by ≥10 % for Group 1 and ≥8 % for Group 2 By
April 1, 2020.

At the start of our QI projects, only 67% and 73%
of patients of age 50-75 had up to date BCS for
Group 1 and Group 2 respectively. By continuous
and dedicated outreach, our BCS score has
improved to 75 % for Group 1 and 77 % for Group
2 on February 20, 2020.

To improve the BCS rates and decrease breast
cancer-related
mortality,
we
established
individualized outreach. Our efforts increased our
QI measures. However, our project was not able
to continue until April 1, 2020 as planned due to
indefinite closure of non-essential clinic visits
starting at the end of February 2020, due to the
COVID-19 pandemic.
Even though we were not able to continue the
project, by continuing these dedicated outreach
reminders, we might have been able to reach our
BCS rate Goal to ≥77 % for Group 1 and ≥80 %
for Group 2 if it weren’t for COVID- 19 Pandemic.

BACKGROUND
Breast cancer (BC) is responsible for the deaths
of over 40,000 women in the USA (1). The United
States Preventive Services Task Force (USPSTF)
recommends biannual mammogram for all women
aged 50-74 years (2). Today, the 5-year survival of
BC is almost 90%, compared to 75% in 1975 (3).
Breast cancer screening (BCS) leads to earlier
detection and treatment, reduced mortality, and
reduced need for the toxic treatments. Despite the
documented screening benefits, only 64-81% of
the population that meets the criteria for regular
BCS is regularly screened (1).

Breast cancer screening
in women ages 50-74
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The study population included our clinic PCPs
from Group 1 (Drs. Sharma, Hunde, and Usmaiel)
and Group 2 (Drs. Peliska, Homida, Hamed,
Boese, Siyum, and Shethwala) who performed
personal outreach to their patients due for BCS.
Every month, data was generated through the
system's QI process, which included the
percentage of eligible BCS patients who are upto-date and a list of patients who are due. The
process for the study was our routine clinic
workflow, in addition to dedicated outreach to our
patients (the intervention). We called, mailed
letters, or messaged through our electronic
messaging system (MyAdvocateAurora) to our
patients who were due for BCS. We advised our
patients to complete a screening mammogram
given supporting facts. A screening mammogram
was ordered for those who agreed. We provided
the patients with a phone number to schedule it.
For patients who had BCS in other systems, we
collected the results through the usual process
and updated them in our system.
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